Robots vs cameras: which surgery wins for lung cancer?

NCT ID NCT06524427

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of minimally invasive surgery for early-stage non-small cell lung cancer: robot-assisted lobectomy (using the Da Vinci system) and video-assisted lobectomy. Over 1,100 participants will be randomly assigned to one of the two procedures. The main goal is to see if robot surgery is at least as good as video surgery in terms of 5-year survival without cancer returning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Robot-assisted lobectomy using Da Vinci surgical system
What this could lead to
If robot-assisted surgery proves better or equal to video-assisted surgery, it could become a preferred option for early-stage lung cancer, potentially improving long-term survival and recovery.
What could go wrong
This is a non-inferiority trial, meaning it aims to show robot surgery is not worse than video surgery, not necessarily better. Results may show no significant advantage, and the study is still recruiting, so outcomes are years away.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • First Affiliated Hospital of Chongqing Medical University

    RECRUITING

    Chongqing, Chongqing Municipality, 400014, China

  • Gansu Provincial Hospital

    RECRUITING

    Lanzhou, Gansu, 730000, China

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510080, China

  • Guangxi Nanxishan Hospital

    RECRUITING

    Guilin, Guangxi, 541002, China

  • Jiangsu Cancer Institute & Hospital

    RECRUITING

    Nanjing, Jiangsu, 210009, China

  • Jiangxi Provincial People's Hopital

    RECRUITING

    Nanchang, Jiangxi, 330006, China

  • Liaoning Tumor Hospital & Institute

    RECRUITING

    Shenyang, Liaoning, 110042, China

  • Qianfoshan Hospital

    RECRUITING

    Jinan, Shandong, 250014, China

  • Qilu Hospital of Shandong University

    RECRUITING

    Jinan, Shandong, 250012, China

  • Shandong Provincial Hospital

    RECRUITING

    Jinan, Shandong, 250022, China

  • Shenzhen People's Hospital

    RECRUITING

    Shenzhen, Guangdong, 518020, China

  • Shenzhen Third People's Hospital

    RECRUITING

    Shenzhen, Guangdong, 518112, China

  • Sichuan Cancer Hospital and Research Institute

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • Sun Yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510060, China

  • Tang-Du Hospital

    RECRUITING

    Xi'an, Shaanxi, 710038, China

  • The Affiliated Hospital of Qingdao University

    RECRUITING

    Qingdao, Shandong, 266003, China

  • The First Affiliated Hospital of Nanchang University

    RECRUITING

    Nanchang, Jiangxi, 330006, China

  • The First Affiliated Hospital of Zhengzhou University

    RECRUITING

    Zhengzhou, Henan, 450052, China

  • The General Hospital of Eastern Theater Command

    RECRUITING

    Nanjing, Jiangsu, 210002, China

  • The Second Hospital of Lanzhou University

    RECRUITING

    Lanzhou, Gansu, 730030, China

  • West China Hospital

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • Wuhan TongJi Hospital

    RECRUITING

    Wuhan, Hubei, 430030, China

  • Wuhan Union Hospital

    RECRUITING

    Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.